HIGHLIGHTS
- who: Kinga u017belechowska-Matysiak and colleagues from the Centre of Radiochemistry and Nuclear Chemistry, Institute of Nuclear Chemistry and Technology, Warsaw, Poland Department of Nanobiotechnology, Institute of Biology, Warsaw University of Life Sciences have published the research: Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ Cancers, in the Journal: Molecules 2023, 28, x FOR PEER REVIEW 12 of the 19 AuNPs, Tmab, AuNPs-DOX, DOX, and DOX-AuNPs-Tmab or non-treated. Data represent of /2023/
- what: The experiments showed that the cytotoxicity of doxorubicin-enhanced nanoparticles and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.